Metastatic Cancer
Electronic symptom reporting reduces ED visits, improves quality of life
Use of a home-based electronic monitoring system for symptom reporting reduced ED visits among people receiving treatment for metastatic cancer, according to study findings.
Importance of addressing cancer survivorship care in light of Kate Middleton’s news
Physicians often experience increased interest and comfortability in patients broaching a health topic once a celebrity talks about it openly in the public eye.
Immune checkpoint inhibitors for advanced lung cancer linked to higher blood clot risk
Treatment with immune checkpoint inhibitors appeared linked with higher risk for venous thromboembolism among adults with metastatic lung cancer, according to study results presented at CHEST Annual Meeting.
Older cancer survivors at elevated risk for cardiovascular disease
Older cancer survivors exhibited increased risk for cardiovascular disease than cancer-free individuals of the same age, according to a secondary analysis of a randomized study.
Platform designed to simplify process of matching, connecting patients to clinical trials
A health technology startup in the United Kingdom has developed an online platform designed to streamline the process through which patients are matched and connected to appropriate clinical trials.
Patients with metastatic cancer, shock benefit from earlier sepsis antibiotics
With earlier receipt of antibiotics for sepsis, those with vs. without metastatic cancer or shock had larger reductions in 30-day mortality, according to results published in American Journal of Respiratory and Critical Care Medicine.
Study reveals gaps in next-generation sequencing for patients with metastatic cancers
Rates of next-generation sequencing have increased for individuals with metastatic prostate cancer or advanced urothelial carcinoma over the past several years, but more than half of these individuals still do not undergo testing.
Clinic designed to minimize autoimmune effects of immunotherapy treatment
A new clinic at The Ohio State University — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Pelotonia Institute for Immuno-Oncology seeks to minimize the autoimmune effects of immunotherapy cancer treatment.
End-of-life immunotherapy on the rise for patients with metastatic cancer
The percentage of patients with advanced cancers who died within a month of beginning immunotherapy rose significantly in the last decade, study results published in JAMA Oncology showed.
Certain cancers linked to elevated readmission, bleeding risk after TAVR
Active cancer during transcatheter aortic valve replacement did not increase in-hospital mortality, but certain cancer types were tied to elevated rehospitalization and major bleeding risk in the following months, researchers reported.